Cochlear Receives FDA Clearance for Osia 3 Sound Processor
Cochlear Limited received FDA clearance for the Osia 3 active bone conduction sound processor, featuring a rechargeable battery, expanded fitting range, a new signal processing chip, and multi-platform wireless streaming, with US availability expected in early fall 2026.